TP53 and myelodysplastic syndrome: We found significant distinct outcomes (P = 0.002) among adverse genetic abnormalities [inv(3), (−5, −7, −17), CK, mutated TP53, CK + TP53, MDS-mutated genes, t(X;11), t(6;9) and t(9;22)].